corporate_fare

Fundacion Instituto De Investigacion Sanitaria De Navarra

Address
Irunlarrea Kalea 3

Sponsor Overview

assignment
2
sponsored trials
science
2
molecules
location_city
14
research centres
public
1
country
person_search
22
investigators

Specializations

Respiratory Medicine

The sponsor is involved in clinical research on chronic obstructive pulmonary disease, with attention to lung function, long-term respiratory decline, and treatment-related outcomes in adults living with chronic airway disease.

  • COPD
  • FEV1
  • Long-term pulmonary function

Its respiratory research activity includes interest in interventions aimed at preserving airflow and assessing changes in pulmonary performance over extended follow-up.

Immune-Mediated Complications

The sponsor also focuses on acute graft-versus-host disease in patients who are steroid-refractory or unable to receive ruxolitinib, reflecting interest in severe post-transplant immune complications.

  • Acute GVHD
  • Steroid-refractory disease
  • Ruxolitinib-intolerant patients

This area centers on difficult-to-treat inflammatory and immune dysregulation after transplantation.

Cell-Based Therapies

Clinical research funded by the sponsor includes investigation of mesenchymal stromal cells derived from adipose tissue, with a therapeutic emphasis on regenerative and immunomodulatory applications.

  • Mesenchymal stromal cells
  • Allogeneic cell therapy
  • Adipose tissue-derived cells

The sponsor’s portfolio shows interest in advanced cellular approaches for immune-related disorders.

Immunomodulation and Targeted Cell Engineering

Another therapeutic domain is the use of genetically modified cells designed to express CXCR4 and IL-10, indicating a focus on immune regulation and cell trafficking in inflammatory disease settings.

  • CXCR4
  • IL-10
  • Genetically engineered cellular products

This research interest aligns with treatment strategies for complex transplant-associated immune injury.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 2 total (50% not shared with other sponsors)

This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
14%
Return partnership rate
2 of 14 sites collaborated multiple times

This sponsor has worked with 14 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Immune System Diseases1 trial
    322 other sponsors
  • 2.
    Respiratory Tract Diseases1 trial
    277 other sponsors

Partnered Research Centres

14 centres
location_city
assignment166
El Hospital Universitario De Gran Canaria Dr. Negrin
Address
Barranco De La Ballena S N, 35010 Las Palmas de Gran Canaria
Learn morearrow_forward
location_city
assignment944
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
Address
Paseo De La Castellana 261, 28046 Madrid
Learn morearrow_forward
location_city
assignment735
Hospital De La Santa Creu I Sant Pau
Address
Carrer De San Quinti 89, 08041 Barcelona
Learn morearrow_forward
location_city
assignment140
Hospital San Pedro De Alcantara
Address
Avenida De Pablo Naranjo Porras S/n, 10002 Cáceres
Learn morearrow_forward
location_city
assignment95
Hospital Son Llatzer
Address
Carretera De Manacor Km 4, 07198 Palma
Learn morearrow_forward
location_city
assignment157
Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida
Address
Avinguda De L'alcalde Rovira Roure 80, 25196 Lleida
Learn morearrow_forward
Page 1 of 3

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Fundacion Instituto De Investigacion Sanitaria De Navarra.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.